CDKN2A and familial pancreatic carcinoma: For instance, in pancreatic cancer cell lines, deletions in the CDKN2A and SMAD4 genes, both of which are common in pancreatic cancer tumors, have in addition to a direct consequence on the coding gene, a three-dimensional consequence altering the contact domains in the area (Du et al., 2022).